![Metod Miklus](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Metod Miklus
Direttore operativo presso DEUTSCHE BIOTECH INNOVATIV AG
Profilo
Metod Miklus is the founder of Marjan Miklus-Stiftung, B.R.A.H.M.S Diagnostika GmbH, Exponat GmbH, ExpoCapital GmbH, and B·R·A·H·M·S GmbH.
He is currently the Chief Operating Officer & Head-Corporate Affairs at Deutsche Biotech Innovativ AG, a Member of the Supervisory Board at AdrenoMed AG and SphingoTec GmbH, and a Member of the Management Board at Marjan Miklus Stiftung zur Förderung der Wissenschaft und.
He holds a doctorate degree from the Technical University of Berlin.
Posizioni attive di Metod Miklus
Società | Posizione | Inizio |
---|---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Direttore operativo | - |
AdrenoMed AG
![]() AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Direttore/Membro del Consiglio | - |
Marjan Miklus Stiftung zur Förderung der Wissenschaft und | Corporate Officer/Principal | - |
SphingoTec GmbH
![]() SphingoTec GmbH BiotechnologyHealth Technology SphingoTec GmbH develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function. The firm specializes in biomarker discovery and acute care diagnostics. The company was founded by Andreas Bergmann in 2002 and is headquartered in Hennigsdorf, Germany. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Metod Miklus
Società | Posizione | Fine |
---|---|---|
ExpoCapital GmbH | Fondatore | - |
Exponat GmbH | Fondatore | - |
B.R.A.H.M.S Diagnostika GmbH | Fondatore | - |
Marjan Miklus-Stiftung | Fondatore | - |
B·R·A·H·M·S GmbH
![]() B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Fondatore | - |
Formazione di Metod Miklus
Technical University of Berlin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Finance |
Aziende private | 8 |
---|---|
B·R·A·H·M·S GmbH
![]() B·R·A·H·M·S GmbH Miscellaneous Commercial ServicesCommercial Services B·R·A·H·M·S GmbH engages in the development and manufacture of novel diagnostic testing procedures. Its products include B·R·A·H·M·S PCT (Procalcitonin), MR-proADM (Mid-regional proadrenomedullin), Copeptin proAVP, Neopterin, and KRYPTOR Instruments. The company was founded in 1994 and is headquartered in Hennigsdorf, Germany. | Commercial Services |
SphingoTec GmbH
![]() SphingoTec GmbH BiotechnologyHealth Technology SphingoTec GmbH develops method for prediction, prevention, intervention of cancer, cardiovascular disease and kidney function. The firm specializes in biomarker discovery and acute care diagnostics. The company was founded by Andreas Bergmann in 2002 and is headquartered in Hennigsdorf, Germany. | Health Technology |
Marjan Miklus-Stiftung | Miscellaneous |
B.R.A.H.M.S Diagnostika GmbH | |
Exponat GmbH | |
ExpoCapital GmbH | |
Marjan Miklus Stiftung zur Förderung der Wissenschaft und | Miscellaneous |
AdrenoMed AG
![]() AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Borsa valori
- Insiders
- Metod Miklus